Showing 1441-1450 of 2235 results for "".
- GC Aesthetics Launches PERLE Breast Implantshttps://modernaesthetics.com/news/gc-aesthetics-launches-perle-breast-implants/2473106/GC Aesthetics is launching PERLE breast implants. PERLE smooth breast implants feature a proprietary surface technology (BioQ), GCA's industry-leading gel technology (Emunomic Breast Tissue Dynamic Gel), and an enhanced version of the safety features. PERLE is initially being rolled
- Allergan to Buy Soliton and Resonic, Its Rapid Acoustic Pulse Devicehttps://modernaesthetics.com/news/allergan-to-buy-soliton/2473103/Allergan Aesthetics is set to acquire Soliton and Resonic, its Rapid Acoustic Pulse device. Resonic recently received U.S. Food and Drug Administration (FDA) 510(k) clearance and is a non-invasive treatment for the short-term improvement in the appearance of cellulite. The acquisition o
- Dr. Deanne Mraz Robinson is Now CMO at Ideal Imagehttps://modernaesthetics.com/news/dr-deanne-mraz-robinson-is-now-cmo-at-ideal-image/2473099/Deanne Mraz Robinson, MD, FAAD has been appointed to serve as Chief Medical Officer for Ideal Image. She will be responsible for the overall direction of treatments and services offered by Ideal Image, the education of its clinical specialists, and he
- Forget Injectables, Patients with Benign Skin Lesions Want Them Gonehttps://modernaesthetics.com/news/forget-injectables-patients-with-benign-skin-lesions-prioritize/2473097/A majority of patients with unwanted benign lesions are interested in a new procedure to clear these lesions, according to a new survey by Pulse Biosciences that was presented at the American Academy of Dermatology (AAD) Virtual Annual Meeting. A diverse sample of 405 aesthetic patients
- Improving Outcomes of Cosmetic Procedures in Patients with Darker Skin Typeshttps://modernaesthetics.com/news/improving-outcomes-of-cosmetic-procedures-in-patients-with-darker-skin-types/2473096/With cosmetic procedures in high demand during the pandemic, Cedars-Sinai dermatologist Jasmine Obioha, MD, has seen an unfortunate side effect: botched treatments for patients of color. When performed improperly, procedures such as chemical peels and laser hair removal can inflame and
- Cynosure Introduces New Fusion Tip for Potenza RF Microneedling System for Enhanced Topical Penetrationhttps://modernaesthetics.com/news/cynosure-introduces-new-fusion-tip-for-potenza-rf-microneedling-system-for-enhanced-topical-penetration/2473094/Cynosure launched a one-of-a-kind Fusion Tip, the newest addition to its Potenza radiofrequency (RF) microneedling system. With its dual-air chamber design, the Fusion Tip captures and releases air towards the skin with each pulse, enhancing the penetration of topicals into the skin by 67 p
- FlawlessCanvas Launches Its First Producthttps://modernaesthetics.com/news/flawlesscanvas-launches-its-first-product/2473084/Quantum Lift Reset Serum™ is now available from FlawlessCanvas, Inc., direct to its Facebook and Instagram followers. “The design of FlawlessCanvas Quantum Lift Reset Serum™ was based on
- Can Fat Grafting Improve Radiation-induced Skin Injury in Cancer Patients?https://modernaesthetics.com/news/can-fat-grafting-improve-radiation-induced-skin-injury-in-cancer-patients/2473077/As cancer survival rates improve, more people are living with the aftereffects of cancer treatment including chronic radiation-induced skin injury. Fat grafting procedures may unleash the healing and regenerative power of the body's natural adipose stem cells (ASCs). "Prelimina
- It's A Deal: Eirion Therapeutics, Shanghai Haohai Biological Technology Close $40M Series A Investment and Licensing Dealhttps://modernaesthetics.com/news/its-a-deal-eirion-therapeutics-inc-shanghai-haohai-biological-technology-closes-40m-series-a-investment-and-licensing-deal/2473070/Eirion Therapeutics, Inc. closed a $40 million Series A investment and licensing deal with Shanghai Haohai Biological Technology Ltd. The deal will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eir
- And The Winner Is... Algeness Named Top Finalist in Terra2 Solution Skin Health Innovation Competitionhttps://modernaesthetics.com/news/and-the-winner-is-algeness-named-top-finalist-in-terra2-solution-skin-health-innovation-competition/2473067/Advanced Aesthetic Technologies, Inc. (AAT) and Algeness are finalists in the recent Terra2 Solutions Skin Health Innovation Competition. Algeness is a patented family of fully resorbable injectable gel implant dermal fillers that are 100% natural and based on purified agarose with